Current State of Drug Development, Clinical Trials, and Precision Measures
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
Emergency departments nationwide are dealing with unparalleled pressure, resulting in prolonged waiting times for patients in A&E and an unacceptable rise of patients receiving their…
Alcidion, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have…
Integrated care is about providing seamless services across a spectrum of healthcare providers. For me, good quality data lies at the crux of truly integrated…
Mark Hindle, vice president EMEA, Orion Health, looks forward to an election year and argues that if political parties are looking for a ‘big idea’…
With each month the NHS waiting list remains at an incredible high, patients anxiously face long waiting times for treatment. As of November 2023, only…
In a world where patients are asking more questions and expecting more from their healthcare, we need to design trials that are truly focused on…
Patient Blood Management (PBM) might ring a bell if you work in a healthcare setting. In layman’s terms, Patient Blood Management is a patient-centered, organized approach…
Ahead of the Digital Health Rewired conference in March 2024, Matthew Taylor explains why innovation and greater use of technology hold significant potential to improve…
While telemedicine and digital health records have helped revolutionize health equity, person-centered care, and access, it is regulations in the healthcare space that are pushing…